Vitamin d and Valturna drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vitamin d (ergocalciferol) and Valturna (aliskiren hemifumarate; valsartan). Common drug interactions include upper gastrointestinal haemorrhage among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Vitamin d and Valturna. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Vitamin d?

Vitamin d has active ingredients of ergocalciferol. It is often used in low vitamin d. eHealthMe is studying from 294,094 Vitamin d users. Check the latest studies of Vitamin d.

What is Valturna?

Valturna has active ingredients of aliskiren hemifumarate; valsartan. It is often used in high blood pressure. eHealthMe is studying from 619 Valturna users. Check the latest studies of Valturna.

On Jul, 09, 2026

34 people who take Vitamin d and Valturna together, and have interactions are studied.

Vitamin d and Valturna drug interactions.

What are the common drug interactions of Vitamin D and Valturna, by gender? *:

female:

Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
Ureteritis (inflammation of the ureter)
Urinary retention (the inability to completely or partially empty the bladder)
Urinary tract infection
Vitamin d decreased
Fall
Fatigue (feeling of tiredness)
Road traffic accident
Weight decreased
Abnormal behaviour

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Hallucination, auditory (perceiving sounds without auditory stimulus)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Oral surgery
Renal injury (kidney injury)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Vitamin D and Valturna, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)

50-59:

Contusion (a type of hematoma of tissue in which capillaries)
Fall
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Joint injury
Joint swelling
Post procedural infection
Tendon rupture (tear of tendon)
Chronic kidney disease
Surgery
Limb injury

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Renal impairment (severely reduced kidney function)
Anaemia (lack of blood)
Death
Fall
Hyperkalaemia (damage to or disease of the kidney)
Renal failure acute (rapid kidney dysfunction)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 23 people, 67.65%
Pain: 7 people, 20.59%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 20.59%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 17.65%
Infection: 6 people, 17.65%
Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 17.65%
Gastric Ulcer (stomach ulcer): 3 people, 8.82%
Blood Calcium Decreased: 3 people, 8.82%
Chest Pain: 3 people, 8.82%
Enlarged Prostate: 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take Vitamin d and Valturna?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously